Hot Investor Mandate 4: Pan-European Venture Firm Invests in Medtech, Digital Health and Life Science Tools

20 Apr

A venture firm with offices in Germany and in Eastern Europe has over €850 million in total assets under management, and has raised a total of six funds; the most recent fund closed in 2016. The firm typically invests €1-5 million in venture-stage opportunities, or up to €15 million in growth-stage opportunities. The firm is currently focused on companies based in Europe.

Within the life science sector the firm is currently focused on medical technology, diagnostics, life science tools, and digital health across Europe. The firm is open to opportunities in any indication area and at any phase of development.

The firm is open to investing in companies at the early commercialization stage, and companies generating steady revenues.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: